{"id":"albendazole-and-ivermectin","safety":{"commonSideEffects":[{"rate":"5-15%","effect":"Gastrointestinal disturbances (nausea, abdominal pain, diarrhea)"},{"rate":"2-10%","effect":"Headache"},{"rate":"1-5%","effect":"Dizziness"},{"rate":"1-10%","effect":"Pruritus (itching)"},{"rate":"1-5%","effect":"Fever"},{"rate":"1-3%","effect":"Elevated liver enzymes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting glucose uptake and energy metabolism. Ivermectin binds to glutamate-gated chloride channels in parasites, causing hyperpolarization, paralysis, and expulsion. Together, this combination targets multiple parasite species through complementary mechanisms.","oneSentence":"Albendazole and ivermectin are antiparasitic agents that disrupt parasite neuromuscular function, causing paralysis and death of helminths and arthropods.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:24:39.088Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Soil-transmitted helminthiasis (roundworm, hookworm, whipworm)"},{"name":"Lymphatic filariasis"},{"name":"Onchocerciasis (river blindness)"},{"name":"Schistosomiasis"},{"name":"Strongyloidiasis"}]},"trialDetails":[{"nctId":"NCT04311671","phase":"PHASE3","title":"Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole","status":"COMPLETED","sponsor":"Medicines Development for Global Health","startDate":"2021-05-03","conditions":"Onchocerciasis","enrollment":12979},{"nctId":"NCT04410406","phase":"PHASE3","title":"Moxidectin for LF, Cote d'Ivoire (DOLF)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-08-20","conditions":"Lymphatic Filariasis","enrollment":164},{"nctId":"NCT03598842","phase":"NA","title":"Tuberculosis - Learning the Impact of Nutrition","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2019-07-12","conditions":"Tuberculosis, Malnutrition, Helminth Infection","enrollment":786},{"nctId":"NCT06070116","phase":"PHASE2","title":"Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-04-05","conditions":"Onchocercal Subcutaneous Nodule, Onchocerciasis, Onchocerciasis, Ocular","enrollment":300},{"nctId":"NCT05124691","phase":"PHASE2, PHASE3","title":"Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms","status":"TERMINATED","sponsor":"Barcelona Institute for Global Health","startDate":"2022-01-20","conditions":"Helminthes; Infestation, Intestinal","enrollment":1001},{"nctId":"NCT06184399","phase":"PHASE2","title":"Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2024-06-05","conditions":"Trichuriasis, Ascariasis, Hookworm Infections","enrollment":260},{"nctId":"NCT06282315","phase":"PHASE3","title":"Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness","status":"RECRUITING","sponsor":"Insud Pharma","startDate":"2025-09-01","conditions":"Soil-Transmitted Helminths","enrollment":20000},{"nctId":"NCT07159373","phase":"PHASE3","title":"Better Options for Lymphatic Filariasis Treatment","status":"NOT_YET_RECRUITING","sponsor":"Medicines Development for Global Health","startDate":"2026-03","conditions":"Lymphatic Filariasis, Scabies, Strongyloidiasis","enrollment":5100},{"nctId":"NCT07045493","phase":"PHASE2","title":"Assessing the Safety and Efficacy of a Combination Therapy for STH in PSAC in Bangladesh","status":"ENROLLING_BY_INVITATION","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2025-07-10","conditions":"Soil Transmitted Helminth (STH) Infections","enrollment":110},{"nctId":"NCT04966702","phase":"PHASE3","title":"Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA)","status":"COMPLETED","sponsor":"Barcelona Institute for Global Health","startDate":"2022-03-17","conditions":"Malaria","enrollment":48145},{"nctId":"NCT06497075","phase":"","title":"Co-administration of IVM and ALB in School-based Deworming in Uganda","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2024-07-01","conditions":"Helminthiasis, Intestinal Worms","enrollment":8767},{"nctId":"NCT04700423","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2021-03-01","conditions":"Trichuriasis, Ascariasis, Hookworm Infections","enrollment":536},{"nctId":"NCT04124250","phase":"","title":"East New Britain Province Monitoring & Evaluation","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-09-17","conditions":"Lymphatic Filariasis Elimination by Mass Drug Administration, Monitoring and Evaluation of Mass Drug Administration for Lymphatic Filariasis, Acceptability of Mass Drug Administration for Lymphatic Filariasis","enrollment":12930},{"nctId":"NCT06265870","phase":"NA","title":"Specific Versus Empirical Anthelminthic Treatment in Eosinophilia","status":"RECRUITING","sponsor":"Prince of Songkla University","startDate":"2024-05-01","conditions":"Eosinophilia","enrollment":700},{"nctId":"NCT04188301","phase":"PHASE2","title":"Safety and Efficacy of IDA for Onchocerciasis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-12-06","conditions":"Onchocerciasis","enrollment":154},{"nctId":"NCT06037876","phase":"PHASE3","title":"Efficacy of Ivermectin-albendazole vs Albendazole Alone in School-aged Children Infected With Trichuris Trichiura","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2023-10-09","conditions":"Trichuriasis","enrollment":161},{"nctId":"NCT03527732","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of IVM/ALB Co-administration","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2018-09-09","conditions":"Trichuriasis","enrollment":1673},{"nctId":"NCT04726969","phase":"PHASE3","title":"Efficacy and Safety of MOX/ALB Co-administration","status":"COMPLETED","sponsor":"Jennifer Keiser","startDate":"2021-06-15","conditions":"Trichuriasis, Ascariasis, Hookworm Infections","enrollment":255},{"nctId":"NCT05283954","phase":"PHASE2, PHASE3","title":"Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea","status":"WITHDRAWN","sponsor":"Oriol Mitja","startDate":"2022-05-01","conditions":"SARS-CoV2 Infection, COVID-19","enrollment":""},{"nctId":"NCT03570814","phase":"PHASE4","title":"Cluster RCT of Co-administration Azithromycin, Albendazole & Ivermectin","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-12-01","conditions":"Trachoma, Lymphatic Filariases","enrollment":13511},{"nctId":"NCT02974049","phase":"NA","title":"Lymphatic Filariasis (LF) in Ivory Coast","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2015-01","conditions":"Lymphatic Filariasis","enrollment":189},{"nctId":"NCT02366884","phase":"PHASE2","title":"Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)","status":"UNKNOWN","sponsor":"Dr. Frank Arguello Cancer Clinic","startDate":"2011-07-26","conditions":"Neoplasms","enrollment":250},{"nctId":"NCT01905436","phase":"","title":"Mass Drug Administration for Lymphatic Filariasis and Onchocerciasis for Liberia","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2012-03","conditions":"Lymphatic Filariasis, Onchocerciasis, Soil Transmitted Helminth (STH) Infections","enrollment":21862},{"nctId":"NCT02899936","phase":"NA","title":"Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic Filariasis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2016-07","conditions":"Lymphatic Filariasis","enrollment":23789},{"nctId":"NCT03352206","phase":"","title":"Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-10-18","conditions":"Lymphatic Filariases","enrollment":20092},{"nctId":"NCT03177993","phase":"NA","title":"Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-07-13","conditions":"Lymphatic Filariases, Scabies, Impetigo","enrollment":4773},{"nctId":"NCT03036059","phase":"PHASE4","title":"Twice Yearly Treatment for the Control of LF","status":"COMPLETED","sponsor":"Noguchi Memorial Institute for Medical Research","startDate":"2017-05-19","conditions":"Lymphatic Filariasis, Helminth Infection","enrollment":1462},{"nctId":"NCT02845713","phase":"PHASE1","title":"Pharmacokinetics & Pharmacodynamics of Diethylcarbamazine (DEC)+ Albendazole (ALB) + Ivermectin (IVE)","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2016-04-17","conditions":"Wuchereria Bancrofti Infection","enrollment":66},{"nctId":"NCT02078024","phase":"PHASE3","title":"Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2014-06","conditions":"Onchocerciasis","enrollment":375},{"nctId":"NCT03676140","phase":"PHASE3","title":"Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-10-01","conditions":"Trachoma, Yaws, Lymphatic Filariases","enrollment":20000},{"nctId":"NCT03664063","phase":"PHASE2","title":"PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )","status":"COMPLETED","sponsor":"Lihir Medical Centre","startDate":"2018-09-01","conditions":"Lymphatic Filariasis, Yaws, Trauma","enrollment":42},{"nctId":"NCT02509481","phase":"PHASE2, PHASE3","title":"Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2015-06","conditions":"Malaria, Lymphatic Filariasis","enrollment":2712},{"nctId":"NCT01975441","phase":"PHASE2","title":"Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2014-05","conditions":"Lymphatic Filariasis","enrollment":182},{"nctId":"NCT02032043","phase":"","title":"Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast (DOLF-Ivory Coast)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2014-02","conditions":"Lymphatic Filariasis, Onchocerciasis, Soil Transmitted Helminth (STH) Infections","enrollment":14457},{"nctId":"NCT00765024","phase":"PHASE3","title":"Ivermectin Versus Albendazole for Chronic Strongyloidiasis","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2008-07","conditions":"Chronic Strongyloidiasis","enrollment":90},{"nctId":"NCT03238131","phase":"PHASE3","title":"IVM Alone vs ALB + IVM Against Onchocerciasis","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2012-04","conditions":"Onchocerciasis","enrollment":272},{"nctId":"NCT00339417","phase":"PHASE2","title":"Effect of Albendazole Dose on Clearance of Filarial Worms","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-02-22","conditions":"Lymphatic Filariasis","enrollment":1000},{"nctId":"NCT02568098","phase":"PHASE1","title":"Pharmacokinetic and Mosquito-Lethal Effects of Ivermectin (IVM), Primaquine (PQ), Dihydroartemisinin-Piperaquine (DHA-PQP) and Albendazole (ABZ) in Healthy Subjects","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2015-10","conditions":"Drug Combination, Pharmacokinetics, Healthy","enrollment":16},{"nctId":"NCT01080989","phase":"NA","title":"The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands","status":"COMPLETED","sponsor":"Kaohsiung Medical University Chung-Ho Memorial Hospital","startDate":"2009-03","conditions":"Flavivirus Infection, Alphavirus Infections, Malaria","enrollment":1477},{"nctId":"NCT02784743","phase":"PHASE4","title":"Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali","status":"COMPLETED","sponsor":"Centre d'Appui à la lutte contre la Maladie","startDate":"2001-05","conditions":"Lymphatic Filariasis","enrollment":1139},{"nctId":"NCT01213576","phase":"NA","title":"Efficacy of Higher Albendazole and Ivermectin Doses on Wuchereria Bancrofti Microfilarial Clearance in Malawi","status":"TERMINATED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2009-01","conditions":"Lymphatic Filariasis","enrollment":70},{"nctId":"NCT01903057","phase":"PHASE4","title":"Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis","status":"WITHDRAWN","sponsor":"Emory University","startDate":"2014-02","conditions":"Trachoma, Lymphatic Filariasis","enrollment":""},{"nctId":"NCT01586169","phase":"NA","title":"Safety of the Co-administration of Three Drugs for Trachoma and Lymphatic Filariasis Elimination","status":"COMPLETED","sponsor":"Centre d'Appui à la lutte contre la Maladie","startDate":"2010-02","conditions":"Parasitic Diseases, Bacterial Diseases","enrollment":3000},{"nctId":"NCT01308268","phase":"NA","title":"Management of Soil-transmitted Helminthiasis and Strongyloidiasis","status":"UNKNOWN","sponsor":"Universidad Nacional de Salta","startDate":"2010-12","conditions":"Helminthiasis, Strongyloides Stercoralis Infection","enrollment":2000},{"nctId":"NCT00817713","phase":"NA","title":"Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?","status":"TERMINATED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2009-01","conditions":"HIV Infections, Helminthiasis","enrollment":295},{"nctId":"NCT01050452","phase":"NA","title":"Safety and Efficacy of Drug Combinations Against Trichuris Trichiura","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","startDate":"2007-10","conditions":"Parasitic Diseases","enrollment":750},{"nctId":"NCT01050517","phase":"NA","title":"Safety and Efficacy of Drug Combinations Against Triple Infections","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","startDate":"2007-10","conditions":"Parasitic Diseases","enrollment":250},{"nctId":"NCT00215280","phase":"NA","title":"Epidemiology and Control of Mansonella Perstans Infection in Uganda","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","startDate":"2005-11","conditions":"Mansonelliasis, Pruritus, Lymphoedema","enrollment":1000},{"nctId":"NCT00207753","phase":"NA","title":"Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2005-02","conditions":"Ascariasis, Trichuriasis, Hookworm Infection","enrollment":550}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zentel and Mectizan"],"phase":"marketed","status":"active","brandName":"''albendazole'' and ''ivermectin''","genericName":"''albendazole'' and ''ivermectin''","companyName":"Centre d'Appui à la lutte contre la Maladie","companyId":"centre-d-appui-la-lutte-contre-la-maladie","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Albendazole and ivermectin are antiparasitic agents that disrupt parasite neuromuscular function, causing paralysis and death of helminths and arthropods. Used for Soil-transmitted helminthiasis (roundworm, hookworm, whipworm), Lymphatic filariasis, Onchocerciasis (river blindness).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}